The fungal alkaloid militarinone A (MiliA) was recently found to stimulate neuronal outgrowth in PC-12 cells by persistant activation of pathways that are also involved in NGF-mediated differentiation, namely the PI3-K/PKB and the MEK/ERK pathways. Application of equal concentrations of MiliA to other cells such as the murine neuroblastoma cell line N2a resulted in immediate onset of apoptosis by nuclear translocation of apoptosis inducing factor (AIF), activation of caspases and c-Jun/AP-1 transcription factor without an intermediate differentiated phenotype, although minor transient phosphorylation of PKB and MAPK as well as activation of NF-jB were also observed. Translocation of AIF was preceded by p53 phosphorylation at Ser15 and blocked by pifithrin a, a known inhibitor of p53-transcriptional activity. We here show that both cell types activate the same pathways albeit in different time scales. This is mainly due to contrasting basal expression levels of p53, which in turn regulates expression of AIF. In PC-12 cells, continuous activation of these pathways after prolonged treatment with 40 lM MiliA first led to up-regulation of p53, phosphorylation of p53, release of AIF from mitochondria and its translocation into the nucleus. Additionally, also activation of the c-Jun/ AP-1 transcription factor was observed, and PC-12 cells subsequently underwent apoptosis 48-72 h post-treatment. We report that similar pathways working on different levels are able to initially shape very divergent cellular responses.
Introduction
Neurotrophic factors are capable of preventing apoptosis in neuronal cells, and exogenous supplementation with such factors have been proposed as a new disease-modifying strategy in the treatment of neurogenerative diseases. However, clinical trials have been disappointing so far due to difficulties in delivery of these glycoproteins into the central nervous system [1] . Small non-peptidic molecules with neurotrophic properties, and capable of penetrating the blood-brain barrier, have been proposed as an alternative [2] . In the course of a screening for such molecules we discovered that the fungal alkaloid militarinone A (MiliA) induced neurite extension in PC-12 cells [3] . Due to its amphiphilic properties MiliA was rapidly integrated into the membranous fraction where it triggered PI3-K/ PKB-and ERK1/2-dependent differentiation [4, 5] . PKB promotes survival of a variety of neuronal cells and has been shown to be required for neuronal outgrowth [6, 7] . In addition, phosphorylation and activation of the MAPKs ERK1/2 [8] have also been connected with neuronal differentiation [9] , albeit its function is not fully clear.
Apoptosis inducing factor (AIF) is a mitochondrial flavoprotein that is mainly located in the mitochondrial intermembrane space. In healthy cells, AIF is required for efficient oxidative phosphorylation. Upon apoptotic insult, it translocates to the cytosol and subsequently into the nucleus where it eventually binds to DNA and induces caspase-independent cell death [10] [11] [12] . The concept that AIF is able to induce apoptotic cell death independent of caspases is supported by a series of experiments where programmed cell death was executed even in presence of chemical caspase inhibitors such as Z-VAD-Fmk (zVAD) or BAF. Moreover, AIF translocation was also observed in mice in the absence of caspase activation [13] , and the biochemical changes were consistent with those described in many caspase-dependent cell death models [14] . Contrasting with its death-inducing properties after nuclear translocation, mitochondria-located AIF has been shown to have a protective role in healthy and in tumour cells [11, 15] . Mitochondrial AIF is even thought to contribute to cell survival by protecting cells against harmful oxidative damage in the absence of deleterious stress while predisposing them to a more efficient killing in response to severe stress. Recently, it has been reported that the aif gene is a transcriptional target of basal levels of p53 [16] .
p53 is a key tumour suppressor protein that is stabilised and phosphorylated due to genotoxic stress and is negatively controlled by Mdm2 which in turn is positively controlled by PI3-K-PKB signalling [17, 18] . Once activated, p53 is able to promote cell-cycle arrest, apoptosis, differentiation, senescence or DNA repair [19, 20] . It may translocate to the nucleus where it regulates a plethora of genes eventually leading to the expression of Bax, Bid, FAS and redox-related genes. Therefore, a model was proposed in which p53 initiates apoptosis through the regulation or generation of reactive oxygen species (ROS) [21] .
ROS are by-products of aerobic oxidation, mediate toxicity but also work as signalling molecules [22] . Among others, ROS activate diverse transcription factors such as AP-1, antioxidant responsive element (ARE) and NF-jB [23] [24] [25] . AP-1 describes a group of related members of the Jun/Fos family and is involved in various cellular processes depending on the composition of AP-1 dimers and on the cell type. It is commonly thought that in neuronal cells, c-jun has pro-apoptotic function [26] , but a simple increase of c-jun concentration was considered to be insufficient to efficiently trigger neuronal cell death [27] . The contribution of AP-1 to survival, apoptosis or differentiation is strictly depending on the cellular situation at a given time point. ARE is important for cell defence under conditions of oxidative stress [24] , and NF-jB is a multifunctional transcription factor mainly involved in promoting cell survival [28] .
Decline of mitochondrial integrity is considered to be of major importance in generation of oxidative stress and induction of apoptosis through the release of AIF and cytochrome c [14, 29] . It is widely accepted that Bcl-2 proteins such as Bax or Bad are able to disturb the outer mitochondrial membrane leading to the release of these small molecules, and that other Bcl-2 proteins such as Bcl-x L or Bcl-2 itself are capable to prevent this.
We report here that the small non-peptidic molecule MiliA is capable of inducing signalling complexes such as PI3-K/PKB, MEK/ERK, p53 and accumulation of ROS that together contribute to neurite extension or/and apoptosis depending on the basal expressional level of p53.
Materials and methods

General remark
All experiments have been successfully reproduced at least three times.
Materials and cell culture
Rat PC-12 cells were a kind gift from Prof. Anne Eckert (Neurobiology Research Laboratory, University Clinic for Psychiatry, Basel, Switzerland). Cells were maintained in Dulbecco's modified Eagle medium (DMEM; SigmaAldrich, Buchs, Switzerland) supplemented with 5% heat-inactivated foetal calf serum (FCS, Amimed, Basel, Switzerland), 10% heat-inactivated horse serum (Amimed, Basel, Switzerland), 100 U/ml penicillin/streptomycin (Invitrogen, Basel, Switzerland), and 2 mM L-glutamine (Invitrogen, Basel, Switzerland). Murine Neuro 2a (N2a) cells were maintained in DMEM supplemented with 10% FCS, 100 U/ml penicillin/streptomycin and 2 mM L-glutamine. Both cell types were grown in humified atmosphere containing 5% CO 2 . PC-12 cells stably overexpressing TrkA were a kind gift from Prof. Frank-D. Böhmer, (Institute of Molecular Cell Biology, Jena, Germany) and were treated as described [3] . The following chemicals have been used: LY294.002, zVAD, pifithrin a (PFTa) (all from Alexis Corporation, Lausen, Switzerland); N-Acetyl-L-cysteine (NAC) and nerve growth factor (NGF) (both from Sigma-Aldrich, Buchs, Switzerland). All chemical inhibitors were added 30 min prior to stimulation.
Western blot
Immunoblot analysis was performed according to standard procedures essentially as described [30] . Nitrocellulose membranes were blocked and incubated overnight at 4°C with specific primary Ab diluted in blocking buffer (5% BSA in TBS-Tween): anti-PKB 1:1000; anti-Phospho-PKB (Ser473) 1:1000; anti-ERK1/2 1:2000; anti-Phospho-ERK1/2 (Thr202/Tyr204) 1:1000; anti-AIF 1:2000; antiPhospho-p53 (Ser15) 1:2000 (all rabbit polyclonal); mouse monoclonal anti-p53 1:1000 (all Cell Signaling Technology, Beverly, MA, USA); goat polyclonal anti-Actin 1:4000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Specific bands were tagged using specific, HRP conjugated secondary Abs and detected using the ECL Plus System (GE Healthcare, Little Chalfont, UK).
Immunofluorescence microscopy and light microscopy PC-12 and N2a cells were fixed in 4% formaldehyde in PBS for a minimal 15 min at 4°C, permabilised with 0.2% Triton-X (prepared in PBS containing 10% heat-inactivated FCS) and then incubated with primary Ab. The Abs were diluted in PBS containing 10% heat-inactivated FCS and used at the following conditions: rabbit polyclonal anti-AIF (diluted 1:50), rabbit anti-Phospho-p53 (Ser15) (diluted 1:100), mouse monoclonal anti-p53 (diluted 1:200) (all from Cell Signaling CST). Subsequently the cells were washed thrice with PBS and incubated for 1 h with affinitypurified Alexa-Fluor 488 goat anti-rabbit IgG (H + L) or Alexa-Fluor 488 goat anti-mouse IgG (H + L) (both from Invitrogen-Molecular Probes, Basel, Switzerland), respectively. Nuclei were counterstained with Dapi (diluted 1:4000 in PBS) (from Invitrogen-Molecular Probes, Basel, Switzerland). Cells plated on coverslips were mounted on glass slides and visualised by confocal microscopy (Leica DM RXE scanning confocal microscope) using Leica confocal software, version 2.5 (Leica Microsystems, Heidelberg, Germany) or on a fluorescence microscope (Axiophot, Carl Zeiss AG, Jena, Germany) using the analySIS Software (Soft Imaging Systems, Münster, Germany). Identical exposure times were used across conditions.
Light microscopy pictures were taken on a Leitz Laborlux (Ernst Leitz, Wetzlar, Germany) equipped with a Leica DC200 Camera (Leitz Microsystems AG, Glattbrugg, Switzerland) and analysed with Leica DC Viewer Software version 3,2,0,0 (Leica Microsystems AG, Heerbrugg, Switzerland).
Flow cytometry and measurement of membrane potential
To detect caspase activation, staining with FITC-valylalanyl-aspartic acid fluoromethyl ketone (FITC-VAD-fmk; Promega) was carried out as described [30] . Annexin V staining of exposed membrane phosphatidylserine was carried out using the Annexin V assay kit (Roche Diagnostics, Rotkreuz, Switzerland) following the manufacturer's protocol. Quantification of loss of membrane potential was determined by incubating 1 9 10 6 cells with 2 nM DiOC 6 (3) in serum-reduced media at 37°C for 30 min. After start of treatment, aliquots were taken at time points indicated, diluted in PBS and subjected to flow cytometry. FACS Analysis was performed on a Dako CyAn TM ADP LX 7 using Summit software (DakoCytomation, Fort Collins, CO, USA).
Measurement of intracellular ROS
The accumulation of ROS in PC-12 and N2a cells was determined by analysis of dichlorofluorescein fluorescence.
Cells were plated in serum-containing DMEM into 96-well plates and allowed to adhere overnight at 37°C. After washing twice with PBS, 2,7-dichlorofluorescein diacetate (DCFH-DA; Invitrogen-Molecular Probes, Basel, Switzerland) was applied at 10 lM in PBS for 45 min at 37°C. After removal of the supernatant, cells were re-suspended in serum-containing DMEM including drugs or vehicle only and incubated for 60 min at 37°C. DCF fluorescence was quantified (excitation: 492 nm; emission: 535 nm) using a Chameleon microplate reader (Hidex Oy, Turku, Finland).
Alternatively, cells were left to grow on coverslips and subsequently loaded with 5 lM DCFH-DA for 30 min. After incubation with drugs in serum-containing DMEM, the cells were fixed with MeOH at -20°C for 5 min and analysed by immunofluorescence microscopy as described above. Identical exposure times were used across conditions. Preparation of nuclear extracts, electrophoretic mobility shift assay and supershift Cells were collected and washed with ice-cold PBS (pH 7.4) and lysed in a hypotonic buffer (10 mM Hepes, pH 7.9, 60 mM KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40) containing protease inhibitors (1 mM PMSF, 19 Complete Ò Protease Inhibitors (Roche Diagnostics, Rotkreuz, Switzerland)). The nuclei were collected by centrifugation at 800g for 5 min at 4°C and washed once in ice-cold hypotonic buffer without NP-40. Nuclei were subsequently re-suspended in nuclear buffer (250 mM Tris-HCl, pH 7.8, 60 mM KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40) containing protease inhibitors (1 mM PMSF, 19 Complete Ò Protease Inhibitors). Nuclear membranes were disrupted by freeze-thawing followed by centrifugation at 13,200g for 30 min. The supernatant (nuclear extract) was collected and the protein concentration was measured using Coomassie Ò Protein Assay Reagent (Sigma-Aldrich, Buchs, Switzerland). The binding reactions were carried out as described [31] . Briefly, nuclear extracts containing 3 lg nuclear proteins were incubated for 20 min with 32 P-radiolabelled oligonucleotides in 20 ll reaction buffer. For supershift analysis, 1 lg of anti-c-jun (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added and incubated on ice for another 30 min. Nuclear protein-oligonucleotide and antibody-protein-oligonucleotide complexes, respectively, were resolved by electrophoresis on a 4% non-denaturing polyacrylamide gel in 0.259 TBE buffer at 20 V/cm for 35 min at room temperature. The gel was dried and autoradiographed on an intensifying screen at -80°C. Double stranded, palindromic oligonucleotides containing the consensus sequences for ARE (5 0 -AAA TGG CAT TGC TAA TGG TGA CAA AGC AAC T-3 0 ) [32] , NF-jB (5 0 -AGT TGA GGG GAC TTT CCC AGG C-3 0 ) [31] or AP-1 (5 0 -GAA TCG AGC ATG AGT CAG ACA CA-3 0 ) [33] were used.
Results
We previously reported [3] that addition of 40 lM MiliA to PC-12 cells for 24 h after pre-treatment with NGF [34] induced neurite outgrowth which was attributed to the NGFdependent up-regulation of its receptor TrkA. However, pretreatment with a commercially available TrkA-inhibitor that was able to prevent NGF-induced phosphorylation of PKB and MAPKs, did not prevent MiliA-dependent phosphorylation of these proteins (Fig. 1a) and suggested that phosphorylation of TrkA was not involved in MiliA-induced neurite extension. When applying 40 lM MiliA to PC-12 cells stably over-expressing TrkA (TA) and naïve PC-12, we observed similar neuronal outgrowth in both cases ( Fig. 1 and [3] . In addition, phosphorylation of PKB and MAPKs in TA (not shown) and naïve PC-12 was found (Fig. 1c) .
Since up-regulation of the PKB and MAPK-pathways was independent of TrkA, we wanted to know if MiliAinduced phosphorylation of these signalling molecules occurred also in other neuronal cell-lines. Treatment of N2a cells with 40 lM MiliA led to a down-regulation of the endogenous PKB and MAPK phosphorylation (Fig. 1  e) . This was accompanied by a marked loss of protein content from samples treated with MiliA compared to vehicle-treated controls (not shown). Moreover, light microscopy revealed that most of the cells had lost adherence, were oddly shaped or had crumbled (Fig. 1d) .
To discriminate between necrotic and apoptotic cell death, we double-stained N2a cells treated with 40 lM MiliA or vehicle only with Annexin V/PI. The overwhelming part of cell death observed was due to apoptotic mechanisms ( Fig. 2a) becoming evident as early as 2 h post-treatment. Additionally, chromatin condensation (Fig. 2c) . We tested in a next step whether pre-treatment with zVAD (20 lM) would be able to suppress onset of apoptosis, but addition of zVAD only slightly diminished the extent of Annexin V-positive cells by -2.3 ± 8.7% (data calculated from six independent experiments), and a complete inhibition was never observed after 3 h of treatment with 40 lM MiliA (Fig. 2d) . Besides, co-incubation of N2a cells with zVAD and MiliA did not slow the progress of apoptosis, and a phenotype showing neurite extension was observed neither in absence nor in presence of zVAD. As caspase-independent pathways could in addition be activated by administration of MiliA, we checked for nuclear translocation of AIF, a protein normally residing in the mitochondrial intermembrane space [10] . In N2a cells, AIF translocation was detected by confocal immunofluorescence microscopy as early as 4-6 h post-treatment (Fig. 2e) . When we checked for simultaneous release of cytochrome c, another pro-apoptotic mitochondrial protein [35] , we failed to detect any significant change in localisation (not shown). These findings suggested a specific release of AIF. As PC-12 showed neurite extension 1 day after addition of 40 lM MiliA, we investigated the effect of prolonged MiliA-treatment on PC-12 cells. Treatment for 1 day only slightly elevated the quantity of Annexin V-positive and Annexin V/PI double-positive cells, but these numbers were substantially increasing after 3 days (Fig. 3a) . However, also PI-positive cells were observed and suggested additional necrotic mechanisms. Next we looked for caspaseactivation using FACS-analysis of FITC-VAD-Fmk-stained cells but failed to detect any activation 1 day post-treatment ( Fig. 3b) . Even after 2 days post-treatment, no activation was observed (not shown). However, most of cells showed clear nuclear translocation of AIF between 2 and 3 days post-treatment (Fig. 3c) and analogous to the situation in N2a cells, no significant change in cytochrome c localisation could be detected.
Militarinone A has been reported to rapidly integrate into the membranous fraction [3] due to its amphiphilic properties [36] , whereas release into the cytoplasm was markedly slower. As both PC-12 and N2a cells showed release of AIF, we isolated whole, viable mitochondria 
from both cell lines to check for membranal integration of MiliA. This rapidly occurred between 30 and 120 s after addition of the compound and was indistinguishable from integration into the cellular membrane (not shown) in both cell types. This observation was unexpected given that N2a showed release of AIF and early apoptosis whereas PC-12 displayed neurite outgrowth and a late onset of cell death. As loss of membrane potential is a sign for the de-stabilisation of mitochondria and a pre-requirement for AIFrelease [37] , we expected to see a rapid depolarisation in N2a, and a significantly slower effect in PC-12. Loss of membrane potential, however, took place at comparable speed in both cell lines (Fig. 4a) . We therefore postulated that PC-12 cells would notwithstanding be less prone to the release of ROS from mitochondria due to loss of membrane potential and we visualised the occurrence of ROS-derived oxidation by measurement of DCF fluorescence via immunofluorescence microscopy. But again, both cell lines reacted in a similar manner to the administration of MiliA (Fig. 4b) . When we quantitatively measured the production of ROS we found no significant difference between PC-12 and N2a cells (Fig. 4c) . Moreover, the production of ROS by 40 lM MiliA was comparable to administration of 100 lM H 2 O 2 and could be efficiently blocked by addition of 15 mM NAC. Given the fact that between depolarisation of the mitochondria and release of ROS, respectively, and induction of cellular death passed several hours (N2a) or even 1-3 days (PC-12), we assume that the release of ROS resulted in activation of signalling pathways not directly involved in apoptosis, as suggested by other publications [38] .
To test the involvement of ROS-production in the propagation of apoptosis and neurite extension, respectively, we co-treated both cell-lines with 40 lM MiliA and 15 mM NAC. PC-12 cells remained unaffected (not shown) and N2a cells showed an apoptotic phenotype indistinguishable from MiliA-only treated cells (Fig. 4d) . Even though NAC blocked accumulation of ROS (Fig. 4c) , the compound did not rescue N2a cells from cell death.
Neither loss of membrane potential nor increase of ROS-levels sufficiently explained the marked difference in reaction of PC-12 and N2a cells to MiliA treatment. Therefore we tested for DNA-binding activities of transcription factors that are reportedly activated by ROS, and bind to consensus sequences of ARE, NF-jB and AP-1 [23] [24] [25] . ARE activity raised rapidly and transiently in N2a and PC-12 after addition of MiliA, reaching its peak after 1 h (Fig. 5a ) as shown by electrophoretic mobility shift assay (EMSA). DNA-binding activity of AP-1 (Fig. 5b) and NF-jB (Fig. 5c) , on the other hand, were differentially regulated in the two cell lines. N2a showed rapid induction of NF-jB and AP-1-binding, peaking between 2 and 4 h. Thereafter, no further activity could be detected. In PC-12 cells, binding of these two transcription factors was more pronounced but only observed from 24-48 h posttreatment.
To test if AP-1 and NF-jB were activated by ROS, we incubated N2a and PC-12 cells pre-treated with 15 mM NAC with MiliA for 4 and 24 h, respectively, and performed EMSA. Only the NF-jB DNA-binding activity was successfully inhibited by NAC in both cell lines (Fig. 5d) , whereas AP-1 remained unaffected (not shown). These experiments suggested that ROS would not directly be involved in MiliA-dependent apoptosis but could contribute to initial survival mechanisms mainly through NF-jB activation.
p53 plays an important role in the management of intracellular stress and regulates basal levels of AIF [16] . AIF appears to play a dual role: it protects cells against oxidative damage when located in the mitochondria, but increases the chance to succumb to cell death in response to severe stress and subsequent translocation of AIF. As there was a distinct release and nuclear translocation of AIF in both cell lines after addition of 40 lM MiliA, we analysed the expression of p53. N2a cells showed a high basal expression of p53 compared to PC-12 cells and a higher expression of AIF (Fig. 6a) . Treatment of PC-12 with MiliA lead to up-regulation of p53, which was almost exclusively localised in the nucleus, whereas N2a cells showed a down-regulation 24 h post-treatment (Fig. 6b, c) . The stabilisation of p53 in PC-12 cells was unexpected, since concommittant activation of PKB occurred (Fig. 1c) . PKB has been reported to negatively regulate p53 through Mdm2 [17] . We, however, found that phosphorylation of PKB positively regulated p53, as co-treatment with LY294.002, a PI3-K-inhibitor, efficiently blocked PKB phosphorylation and stabilisation of p53 (Fig. 6b) . A similar finding was previously published for p53 activation by cisplatin that was equally blocked by the PI3-K-inhibitor [39] . LY294.002, however, did not interfere with the MiliA-dependent down-regulation but led to a slightly diminished expression of basal p53 in untreated N2a cells after incubation with LY294.002 for 1 day (Fig. 6b) .
As we had suggested that high p53 expression in N2a cells might be responsible for the sensitisation towards apoptosis induced by MiliA, it was surprising to find p53 down-regulation after 24 h in N2a. However, this downregulation only occurred after induction of apoptosis. A time course experiment of p53 expression did neither show up-nor down-regulation within 4 h post-treatment (Fig. 6  d) . To analyse activation of p53, we used an antibody directed against the phosphorylated form of p53 (Ser15), which was shown to be essential for its pro-apoptotic activity [40, 41] . We, however, only found a significant increase 4 h after addition of 40 lM MiliA, essentially before AIF translocation was observed (Figs. 6e and 2e) . In PC-12 cells, stabilisation and activation by phosphorylation of p53 was not observed before 24 h post-treatment, but well before translocation of AIF could be detected (Figs. 6e and 3c) .
To check if activation of p53 was indeed responsible for release of AIF and its nuclear translocation, we added MiliA to cells pre-treated for 30 min with PFTa, a known inhibitor of p53-transcriptional activity [42] . Consequently, localisation of AIF remained unchanged in PFTa pretreated cells upon administration of MiliA in both cell types after 6 h (N2a; Fig. 7a ) and 3 days (PC-12; Fig. 7c) , respectively. Further, we checked if induction of apoptosis could be blocked by pre-treatment with PFTa and/or PFTa/ zVAD combined treatment, which in fact was the case: PFTa alone or in combination with zVAD efficiently blocked initiation of apoptosis as measured by FACS of Annexin V/PI-double stained cells in both N2a (Fig. 7b) and PC-12 cells (Fig. 7d) . zVAD (20 lM) alone, however, only showed marginal reduction of Annexin V-positive cells in N2a and no reduction in PC-12. This is in agreement with the finding that PC-12 showed no caspaseactivation in our assays in response to MiliA (Fig. 3b) . Even application of up to 100 lM zVAD did not block onset of programmed cell death in neither cell line (not shown). As LY294.002 blocked stabilisation of p53, we tested if treatment with the inhibitor 30 min prior to addition of MiliA would reduce the extent of cell death in N2a. Co-treatment with LY294.002 efficiently inhibited binding of Annexin-V after 3 h, and only a fraction of the cells lost their shape and adherence after 24 h (Fig. 8a, b) .
As treatment with LY294.002 slightly reduced basal levels of p53 in N2a cells (Fig. 6b) , we investigated whether phosphorylation at Ser15 of p53 would be repressed as well. Use of an antibody directed against P-p53 in immunofluorescence microscopy showed that activation of p53 by 40 lM MiliA was indeed affected by pre-treatment with LY294.002 (Fig. 8c) . 95.5 ± 4.1% of MiliA-treated cells showed phosphorylation of p53 in immunofluorescence microscopy vs. 55.2 ± 4.2% in MiliA/LY294.002 co-treated cells (data calculated from three independent experiments). This reduction was confirmed by analysis of protein samples by SDS-PAGE (Fig. 8d) and was obviously sufficient to prevent immediate onset of apoptosis. However, MiliA-treated N2a cells in presence of LY294.002 succumbed to cell death between 24 and 48 h post-treatment (not shown).
Given that pre-treatment with LY294.002 prolonged survival of MiliA-treated N2a cells, we also applied the PI3-K-inhibitor to PC-12 cells to see if neurite extension and/or late apoptosis would be inhibited. However, PC-12 cells died within 24 h after addition of 50 lM LY294.002 in presence, but also in absence of 40 lM MiliA (not shown). Therefore we continued with N2a cells and observed postponed MiliA-dependent activation of the AP-1 transcription factor in presence of LY294.002 24 h after start of treatment. Interestingly, DNA-binding activity of AP-1 was not detected in MiliA-only treated cells at this time point (Figs. 9a and 5b) . MiliA-dependent NF-jB DNA-binding activity on the other hand remained unchanged in presence or absence of LY294.002 ( Fig. 5c and not shown). We therefore tested the hypothesis, that raised AP-1 DNA-binding activity is a pro-apoptotic event in this context [43] . As binding of c-jun to AP-1 consensus sequences is considered to be pro-apoptotic [26] , we performed supershift analysis using a specific antibody directed against c-jun. We found c-jun-binding in both in MiliA-treated N2a after 4 h as well as in PC-12 after 24 h (Fig. 9b) . In addition, the same supershift was also observed in N2a cells co-treated with LY294.002 and MiliA after 24 h (not shown).
Discussion
In this study we present evidence that a simple molecule by activating identical pathways is able to trigger events as diverse as neurite extension and apoptosis.
Differentiation is a complex process and involves diverse signalling pathways. In PC-12 cells, neuronal differentiation is usually initiated by the binding of NGF to TrkA and involves the subsequent activation of PI3-K/ PKB, PKCs, Ras and MEK/ERK [5] . MiliA, a pyridone alkaloid from Paecilomyces militaris [36] basically does the same: it activates PKB and ERK1/2 [3] but circumvents the need for TrkA. This results in neurite extension in PC-12, and apoptosis in N2a cells. The outcome is similar to that reported for geldanamycin, an Hsp90 inhibitor, which provoked programmed cell death in PC-12 and neurite extension in N2a cells [44] . In another study using a MiliArelated compound, (+)-N-Deoxymilitarinone A, cytotoxic effects were observed in the human neuroblastoma cell line IMR-32, and neurite extension in PC-12 cells [45] .
We report that MiliA is capable of initially driving two basically independent signalling pathways. First, it provides NGF-like activity, leading to neurite extension. The mechanism for activation of PI3-K/PKB and MEK/ERK1/ 2, however, remains elusive. As MiliA showed high affinity for membraneous compartments, we investigated possible stimulation of the small G-proteins Ras and Rac which are activated at the cytoplasmic side of the cellular membrane [9, 46, 47] but could not detect any consisting and specific activation neither at early nor late time points (data not shown).
By additional insertion into mitochondrial membranes, MiliA disturbed their integrity, which resulted in loss of membrane potential, release and accumulation of ROS, in both cell lines at comparable speed. Since addition of NAC blocked increase of ROS in PC-12 and N2a, but not the apoptotic pace, we assume that the release of oxidative molecules from mitochondria did not trigger apoptosis by itself. Furthermore, NAC did not inhibit cellular death in N2a and blocked NF-jB-activation suggested that accumulation of ROS was involved in defence and survival mechanisms. The subsequent release of AIF and its translocation to the nucleus was fast in N2a but delayed in PC-12, and suggests involvement of additional elements that control release of molecules at mitochondrial level [48] . This was corroborated by the fact that we were unable to detect co-release of cytochrome C. How exactly MiliA induces loss of membrane potential, a necessary pre-requisite for subsequent release of AIF [37] , needs further investigation.
Second, it activates p53-dependent apoptosis [19, 20] mainly through a caspase-independent mechanism involving nuclear translocation of AIF, a molecule that is positively regulated by basal levels of p53 [16] . N2a showed higher basal levels of p53 and AIF and underwent apoptosis within a few hours whereas PC-12 had a low p53-expression and first reacted with up-regulation of protein-levels before execution of programmed cell death. In the course of MiliA-induced signalling we found additional phosphorylation of p53 at Ser15, which is essential for its pro-apoptotic function [40, 41] . Using PFTa, a compound that does not inhibit p53 phosphorylation but its transcriptional activity, abolished MiliA-dependent AIF translocation and initiation of apoptosis. This suggests that p53 was involved in regulation of AIF-expression and localisation. However, these pathways described are not independent but interact with each other. Whereas inhibition of ERK1/ 2-signalling by the MEK-inhibitor UO126 had not specific effect (data not shown), blocking of the PI3-K/PKB pathway by LY294.002 suppressed MiliA-dependent early execution of apoptosis in N2a cells. This finding is in contrast to reports showing that inhibition of PI3-K would lead to stabilisation of p53 and facilitated induction of apoptosis [17, 49] : rather on the contrary, basal expression as well as phosphorylation at Ser15 were moderately repressed. It is, however, in agreement with reports that showed inhibition of cisplatin-induced, p53-dependent apoptosis by LY294.002 [39] . Although the PI3-K/PKBpathway is mainly known for its pro-survival activity [50] , it contributes in this complex context to apoptosis-induction. Additionally, it postponed MiliA-dependent AP-1 DNA-binding activity.
A differentiated phenotype in N2a cells could not be observed, which is likely due to the inhibition of PKBderived signalling. Unfortunately, this assumption could not be verified in PC-12 cells as they fatally reacted to PI3-K-inhibition as described.
It seems clear that the two cell-lines undergo apoptosis through the same mechanisms once they are activated to a similar extent. Further, it seems to be clear that MiliAdependent ROS-production does not play a decisive role as both showed almost identical ROS-up-regulation. We nevertheless assume that it was involved to a certain degree. ROS also act as secondary messengers in intracellular signal transduction and help to induce or maintain the oncogenic phenotype of cancer cells [51] . Treatment with MiliA may just have driven the delicate balance over the edge. Preliminary data suggest that MiliA-treated primary cells (bovine lymph node cells and murine bone marrow mast cells) did not undergo cellular death even after a week's incubation. All cancer or cancerous cell lines tested on the other hand (PC-12, N2a, IMR-32, Jurkat T-cells, Theileria parva-infected T-cells [52] ) died between 8 and 72 h after start of treatment (P. Küenzi and M. Hamburger, unpublished results).
Conclusion
Militarinone A induces neurite extension in PC-12 cells by persistent activation of pathways that are also involved in NGF-mediated differentiation, namely the PI3-K/PKB and MEK/ERK pathways. The continuous activation of these pathways finally leads to up-regulation of p53, release of AIF from mitochondria, and activation of the c-Jun/AP-1 transcription factor that has also been described as a ''killer on the transcriptional leash'' [43] . Application of MiliA to N2a cells, however, resulted in rapid onset of apoptosis by nuclear translocation of AIF, activation of caspases and c-Jun/AP-1. The main difference between the two cell types was the basal expression of p53, being high in N2a and low in PC-12. MiliA induced further stabilisation and activation of p53 as well as p53-dependent release and nuclear translocation of AIF in PC-12, which eventually resulted in apoptosis. MiliA induced the self-same pathways in both cell lines, initially leading to diverse, but finally to identical results.
